Document is current
Any future updates will be listed below
-
Authors
Schindler, Louise S.
Gill, Dipender
Oppenheimer, Hannah
Barth, Claudia
Andreassen, Ole A.
Draganski, Bogdan
Westlye, Lars T.
Topiwala, Anya
de Lange, Ann-Marie G.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Helse Sør-Øst RHF
the European Research Council under the European Union’s Horizon 2020 research and innovation programme
European Union Horizon Europe
Fondation Leenaards
The Research Council of Norway
The Wellcome Trust
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 6 February 2026
First Online: 28 February 2026
Competing interests
: D.G. is chief executive officer of Sequoia Genetics, a private limited company that works with investors, pharma, biotech, and academia by performing research that leverages genetic data to help inform drug discovery and development, but declares no non-financial competing interests. All authors declare no financial or non-financial competing interests.
